227 related articles for article (PubMed ID: 31337800)
1. HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory molecules.
Ackermann C; Smits M; Woost R; Eberhard JM; Peine S; Kummer S; Marget M; Kuntzen T; Kwok WW; Lohse AW; Jacobs T; Boettler T; Schulze Zur Wiesch J
Sci Rep; 2019 Jul; 9(1):10624. PubMed ID: 31337800
[TBL] [Abstract][Full Text] [Related]
2. Expression of programmed cell death protein 1 and T-cell immunoglobulin- and mucin-domain-containing molecule-3 on peripheral blood CD4+CD8+ double positive T cells in patients with chronic hepatitis C virus infection and in subjects who spontaneously cleared the virus.
Caraballo Cortés K; Osuch S; Perlejewski K; Pawełczyk A; Kaźmierczak J; Janiak M; Jabłońska J; Nazzal K; Stelmaszczyk-Emmel A; Berak H; Bukowska-Ośko I; Paciorek M; Laskus T; Radkowski M
J Viral Hepat; 2019 Aug; 26(8):942-950. PubMed ID: 30972915
[TBL] [Abstract][Full Text] [Related]
3. Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors.
Kroy DC; Ciuffreda D; Cooperrider JH; Tomlinson M; Hauck GD; Aneja J; Berger C; Wolski D; Carrington M; Wherry EJ; Chung RT; Tanabe KK; Elias N; Freeman GJ; de Kruyff RH; Misdraji J; Kim AY; Lauer GM
Gastroenterology; 2014 Feb; 146(2):550-61. PubMed ID: 24148617
[TBL] [Abstract][Full Text] [Related]
4. TIGIT expression is upregulated in T cells and causes T cell dysfunction independent of PD-1 and Tim-3 in adult B lineage acute lymphoblastic leukemia.
Zhang X; Zhang H; Chen L; Feng Z; Gao L; Li Q
Cell Immunol; 2019 Oct; 344():103958. PubMed ID: 31376919
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.
Raziorrouh B; Ulsenheimer A; Schraut W; Heeg M; Kurktschiev P; Zachoval R; Jung MC; Thimme R; Neumann-Haefelin C; Horster S; Wächtler M; Spannagl M; Haas J; Diepolder HM; Grüner NH
Gastroenterology; 2011 Oct; 141(4):1422-31, 1431.e1-6. PubMed ID: 21763239
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute
Herrmann M; Schulte S; Wildner NH; Wittner M; Brehm TT; Ramharter M; Woost R; Lohse AW; Jacobs T; Schulze Zur Wiesch J
Front Immunol; 2020; 11():1870. PubMed ID: 32983106
[TBL] [Abstract][Full Text] [Related]
7. Deciphering the Plasmodium falciparum malaria-specific CD4+ T-cell response: ex vivo detection of high frequencies of PD-1+TIGIT+ EXP1-specific CD4+ T cells using a novel HLA-DR11-restricted MHC class II tetramer.
Schulte S; Heide J; Ackermann C; Peine S; Ramharter M; Mackroth MS; Woost R; Jacobs T; Schulze Zur Wiesch J
Clin Exp Immunol; 2022 Apr; 207(2):227-236. PubMed ID: 35020841
[TBL] [Abstract][Full Text] [Related]
8. Peripheral PD-1
Romani S; Stafford K; Nelson A; Bagchi S; Kottilil S; Poonia B
Front Immunol; 2019; 10():1470. PubMed ID: 31316516
[TBL] [Abstract][Full Text] [Related]
9. CD8
Osuch S; Laskus T; Perlejewski K; Berak H; Bukowska-Ośko I; Pollak A; Zielenkiewicz M; Radkowski M; Caraballo Cortés K
Front Immunol; 2022; 13():832206. PubMed ID: 35386708
[TBL] [Abstract][Full Text] [Related]
10. Virus-Specific CD4+ T Cells Have Functional and Phenotypic Characteristics of Follicular T-Helper Cells in Patients With Acute and Chronic HCV Infections.
Raziorrouh B; Sacher K; Tawar RG; Emmerich F; Neumann-Haefelin C; Baumert TF; Thimme R; Boettler T
Gastroenterology; 2016 Mar; 150(3):696-706.e3. PubMed ID: 26584604
[TBL] [Abstract][Full Text] [Related]
11. CD8
Wang M; Bu J; Zhou M; Sido J; Lin Y; Liu G; Lin Q; Xu X; Leavenworth JW; Shen E
Clin Immunol; 2018 May; 190():64-73. PubMed ID: 28893624
[TBL] [Abstract][Full Text] [Related]
12. High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome.
Kasprowicz V; Schulze Zur Wiesch J; Kuntzen T; Nolan BE; Longworth S; Berical A; Blum J; McMahon C; Reyor LL; Elias N; Kwok WW; McGovern BG; Freeman G; Chung RT; Klenerman P; Lewis-Ximenez L; Walker BD; Allen TM; Kim AY; Lauer GM
J Virol; 2008 Mar; 82(6):3154-60. PubMed ID: 18160439
[TBL] [Abstract][Full Text] [Related]
13. Double Positive CD4
Kochanowicz AM; Osuch S; Berak H; Kumorek A; Caraballo Cortés K
Cells; 2023 May; 12(10):. PubMed ID: 37408280
[TBL] [Abstract][Full Text] [Related]
14. Decrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis C.
Osuch S; Laskus T; Berak H; Perlejewski K; Metzner KJ; Paciorek M; Radkowski M; Caraballo Cortés K
Sci Rep; 2020 Sep; 10(1):16060. PubMed ID: 32994477
[TBL] [Abstract][Full Text] [Related]
15. A novel assay for detection of hepatitis C virus-specific effector CD4(+) T cells via co-expression of CD25 and CD134.
Keoshkerian E; Helbig K; Beard M; Zaunders J; Seddiki N; Kelleher A; Hampartzoumian T; Zekry A; Lloyd AR
J Immunol Methods; 2012 Jan; 375(1-2):148-58. PubMed ID: 22019644
[TBL] [Abstract][Full Text] [Related]
16. CD8+ T cells of chronic HCV-infected patients express multiple negative immune checkpoints following stimulation with HCV peptides.
Barathan M; Mohamed R; Vadivelu J; Chang LY; Vignesh R; Krishnan J; Sigamani P; Saeidi A; Ram MR; Velu V; Larsson M; Shankar EM
Cell Immunol; 2017 Mar; 313():1-9. PubMed ID: 28104239
[TBL] [Abstract][Full Text] [Related]
17. Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection.
Missale G; Pilli M; Zerbini A; Penna A; Ravanetti L; Barili V; Orlandini A; Molinari A; Fasano M; Santantonio T; Ferrari C
Gut; 2012 Jul; 61(7):1076-84. PubMed ID: 22337949
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus-specific CD4+ T cell phenotype and function in different infection outcomes.
Chen DY; Wolski D; Aneja J; Matsubara L; Robilotti B; Hauck G; de Sousa PSF; Subudhi S; Fernandes CA; Hoogeveen RC; Kim AY; Lewis-Ximenez L; Lauer GM
J Clin Invest; 2020 Feb; 130(2):768-773. PubMed ID: 31904582
[TBL] [Abstract][Full Text] [Related]
19. According to Hepatitis C Virus (HCV) Infection Stage, Interleukin-7 Plus 4-1BB Triggering Alone or Combined with PD-1 Blockade Increases TRAF1
Moreno-Cubero E; Subirá D; Sanz-de-Villalobos E; Parra-Cid T; Madejón A; Miquel J; Olveira A; González-Praetorius A; García-Samaniego J; Larrubia JR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093082
[TBL] [Abstract][Full Text] [Related]
20. Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity.
McMahan RH; Golden-Mason L; Nishimura MI; McMahon BJ; Kemper M; Allen TM; Gretch DR; Rosen HR
J Clin Invest; 2010 Dec; 120(12):4546-57. PubMed ID: 21084749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
